Literature DB >> 8150023

Retinomotor movements in isolated teleost retinal cone inner-outer segment preparations (CIS-COS): effects of light, dark and dopamine.

B Burnside1, E Wang, K Pagh-Roehl, H Rey.   

Abstract

Teleost cone inner segments elongate and contract in response to light and circadian signals. Previous studies have shown that teleost cone contraction is triggered by light or dopamine, while cone elongation is triggered by darkness or experimental elevation of cAMP. We have developed procedures for isolating and purifying motile cone fragments consisting of inner and outer segments (CIS-COS) to permit more detailed analysis of light and dopamine regulation of cone retinomotor movements. When retinas are dissected from long-term dark-adapted fish, CIS-COS break off at the base of the ellipsoid and remain attached to the RPE. CIS-COS can be detached from the RPE by brief protease treatment, thereby generating a highly enriched CIS-COS suspension. CIS-COS retain normal morphology and extend new myoids when cultured in darkness or in light plus forskolin, an activator of adenylate cyclase. The microtubule and actin cytoskeletons of the new myoids resemble those of intact cone myoids in vivo. Light inhibits CIS-COS myoid elongation, suggesting that light reception by the outer segment can directly influence cone motility. In dark-cultured CIS-COS, myoid elongation is inhibited half-maximally by nanomolar concentrations of dopamine, suggesting that dopamine effects on motility are mediated by D2-family receptors present on the cone inner and/or outer segment. After dark-induced elongation in culture, CIS-COS myoids can be induced to contract by subsequent culture in the light or with dopamine. Thus isolated cone inner and outer segments possess sufficient cytoskeletal and regulatory machinery to exhibit light- and dopamine-regulation retinomotor movement similar to that observed in intact cones in situ.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8150023     DOI: 10.1006/exer.1993.1179

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  7 in total

1.  Mitochondria Maintain Distinct Ca2+ Pools in Cone Photoreceptors.

Authors:  Michelle M Giarmarco; Whitney M Cleghorn; Stephanie R Sloat; James B Hurley; Susan E Brockerhoff
Journal:  J Neurosci       Date:  2017-01-23       Impact factor: 6.167

2.  Circadian phase-dependent modulation of cGMP-gated channels of cone photoreceptors by dopamine and D2 agonist.

Authors:  Gladys Y-P Ko; Michael L Ko; Stuart E Dryer
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

3.  Identification and localization of myosin superfamily members in fish retina and retinal pigmented epithelium.

Authors:  Jennifer Lin-Jones; Lorraine Sohlberg; Andréa Dosé; Jennifer Breckler; David W Hillman; Beth Burnside
Journal:  J Comp Neurol       Date:  2009-03-10       Impact factor: 3.215

Review 4.  Role of dopamine in distal retina.

Authors:  E Popova
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2014-04-12       Impact factor: 1.836

5.  Usherin defects lead to early-onset retinal dysfunction in zebrafish.

Authors:  Margo Dona; Ralph Slijkerman; Kimberly Lerner; Sanne Broekman; Jeremy Wegner; Taylor Howat; Theo Peters; Lisette Hetterschijt; Nanda Boon; Erik de Vrieze; Nasrin Sorusch; Uwe Wolfrum; Hannie Kremer; Stephan Neuhauss; Jingjing Zang; Maarten Kamermans; Monte Westerfield; Jennifer Phillips; Erwin van Wijk
Journal:  Exp Eye Res       Date:  2018-05-16       Impact factor: 3.467

6.  Cone myoid elongation involves unidirectional microtubule movement mediated by dynein-1.

Authors:  Tylor R Lewis; Mariusz Zareba; Brian A Link; Joseph C Besharse
Journal:  Mol Biol Cell       Date:  2017-11-15       Impact factor: 4.138

7.  Circadian plasticity in photoreceptor cells controls visual coding efficiency in Drosophila melanogaster.

Authors:  Martin Barth; Michael Schultze; Christoph M Schuster; Roland Strauss
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.